Health HiberCell to Present Preclinical Data from Novel GCN2 Activator and PERK Inhibitor Programs at The… James Pereira Nov 3, 2022 NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- HiberCell, a clinical-stage biotechnology company developing therapeutics… Read More...
Health Spring Activator launches Health Impact Investor Challenge accelerating early-stage healthcare… James Pereira Dec 1, 2021 VANCOUVER, British Columbia, Nov. 30, 2021 (GLOBE NEWSWIRE) -- On a mission to accelerate investment in impact… Read More...
